FDA Globalization Act Too Taxing For Small Biz? Group Lobbies For Exemption
This article was originally published in The Rose Sheet
Executive Summary
The draft version of the FDA Globalization Act of 2008 may be amended to include exemptions for small cosmetics firms that otherwise would be "decimated" under the legislation in its current form, according to a group of small business owners and representatives that has been active on Capitol Hill
You may also be interested in...
2009 FDA Globalization Act Scratches Fees For Cosmetics, “Unanticipated” AEs
The latest version of the FDA Globalization Act includes a number of changes beneficial to small cosmetic firms; however, the draft legislation still presents some overly burdensome requirements, according to Indie Beauty Network founder and CEO Donna Maria Coles Johnson, Esq
2009 FDA Globalization Act Scratches Fees For Cosmetics, “Unanticipated” AEs
The latest version of the FDA Globalization Act includes a number of changes beneficial to small cosmetic firms; however, the draft legislation still presents some overly burdensome requirements, according to Indie Beauty Network founder and CEO Donna Maria Coles Johnson, Esq
House Subcommittee Hearing Explores Alleged Gaps In Cosmetic Safety
Legislative proposals that would require cosmetics companies to report adverse events to FDA and register their manufacturing facilities were the focus of discussion among panelists testifying on Capitol Hill May 14 on a draft version of the Food and Drug Administration Globalization Act of 2008